For the first time, doctors have utilized a gene-editing therapy tailored to a baby born with a rare, life-threatening genetic disorder. The treatment involved infusing billions of microscopic gene editors to target and repair a specific mutation in the baby’s liver. Early results indicate the therapy has at least partially reversed the condition, potentially preventing brain damage and death, marking a significant step in personalized medicine for rare diseases.